I think medivet shareholders shares come out of escrow shortly which may increase selling pressure as they seek to exit. DYOR IMHO etc
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025